title: Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.
abstract: The Hedgehog (Hh) signaling pathway is critical for embryonic development. In adult tissues, Hh signaling is relatively quiescent with the exception of roles in tissue maintenance and repair. Aberrant activation of Hh signaling is implicated in multiple aspects of transformation, including the maintenance of the cancer stem cell (CSC) phenotype. Preclinical studies indicate that CSCs from many tumor types are sensitive to Hh pathway inhibition and that Hh-targeted therapeutics block many aspects of transformation attributed to CSCs, including drug resistance, relapse, and metastasis. However, to date, Hh inhibitors, specifically those targeting Smoothened [such as vismodegib, BMS-833923, saridegib (IPI-926), sonidegib/erismodegib (LDE225), PF-04449913, LY2940680, LEQ 506, and TAK-441], have demonstrated good efficacy as monotherapy in patients with basal cell carcinoma and medulloblastoma, but have shown limited activity in other tumor types. This lack of success is likely due to many factors, including a lack of patient stratification in early trials, cross-talk between Hh and other oncogenic signaling pathways that can modulate therapeutic response, and a limited knowledge of Hh pathway activation mechanisms in CSCs from most tumor types. Here, we discuss Hh signaling mechanisms in the context of human cancer, particularly in the maintenance of the CSC phenotype, and consider new therapeutic strategies that hold the potential to expand considerably the scope and therapeutic efficacy of Hh-directed anticancer therapy.
authors: Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
authors: Verline
authors: V
authors: Justilien
authors: Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida. fields.alan@mayo.edu.
authors: Alan P
authors: AP
authors: Fields
mesh_terms: D000818:Animals; D053823:Hedgehog Proteins / Q000378:metabolism*; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects; D057170:Translational Research, Biomedical
chemical_list: D053823:Hedgehog Proteins
references: Science. 2012 Aug 10;337(6095):730-5
references: 22855427
references: Nature. 2008 Sep 18;455(7211):406-10
references: 18754008
references: Sci Transl Med. 2010 Sep 29;2(51):51ra70
references: 20881279
references: Clin Cancer Res. 2007 Mar 1;13(5):1389-98
references: 17332280
references: Cancer Res. 2011 Nov 15;71(22):7061-70
references: 21975935
references: Trends Pharmacol Sci. 2009 Jun;30(6):303-12
references: 19443052
references: Proc Natl Acad Sci U S A. 2007 May 15;104(20):8455-60
references: 17494766
references: Nat Chem Biol. 2013 Apr;9(4):247-9
references: 23416332
references: Nature. 2012 Aug 23;488(7412):522-6
references: 22854781
references: Int J Oncol. 2012 Nov;41(5):1707-14
references: 22923052
references: Clin Cancer Res. 2012 Dec 1;18(23):6509-18
references: 23032746
references: Cancer Invest. 2013 Aug;31(7):480-9
references: 23915072
references: Prostate. 2013 Dec;73(16):1810-23
references: 24105601
references: Cancer Cell. 2012 Sep 11;22(3):373-88
references: 22975379
references: Endocr Relat Cancer. 2007 Sep;14(3):865-74
references: 17914115
references: Cancer Sci. 2009 Oct;100(10):1848-55
references: 19622100
references: Mol Cell Biochem. 2012 May;364(1-2):235-41
references: 22350753
references: Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4616-21
references: 12679522
references: Nat Med. 2011;17(11):1504-8
references: 21983857
references: Clin Cancer Res. 2010 Jun 15;16(12):3130-40
references: 20530699
references: Oncogene. 2008 Aug 14;27(35):4841-53
references: 18427549
references: Cancer Res. 2011 Feb 1;71(3):1092-102
references: 21135115
references: Biochem Biophys Res Commun. 2012 Aug 17;425(1):64-9
references: 22820185
references: Cancer Cell. 2014 Feb 10;25(2):139-51
references: 24525231
references: Nature. 2003 Oct 23;425(6960):846-51
references: 14520411
references: Nature. 2013 Feb 28;494(7438):484-8
references: 23446420
references: J Biol Chem. 2010 Aug 20;285(34):26570-80
references: 20504762
references: Nat Med. 2007 Aug;13(8):944-51
references: 17632527
references: Cancer Treat Rev. 2014 Jul;40(6):750-9
references: 24613036
references: Clin Cancer Res. 2012 Mar 1;18(5):1291-302
references: 21868763
references: Cancer Sci. 2007 Jan;98(1):68-76
references: 17083567
references: Mol Cancer Ther. 2012 Jul;11(7):1587-97
references: 22553355
references: Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14132-7
references: 19666565
references: Nature. 2004 Oct 7;431(7009):707-12
references: 15361885
references: J Biol Chem. 2013 Apr 26;288(17):11786-94
references: 23482563
references: Nat Rev Genet. 2010 May;11(5):331-44
references: 20395968
references: Oncogene. 2007 Aug 16;26(38):5674-9
references: 17353904
references: PLoS One. 2012;7(6):e40021
references: 22768203
references: Clin Cancer Res. 2014 Aug 1;20(15):3974-88
references: 24947926
references: Anticancer Res. 2013 Jun;33(6):2415-24
references: 23749890
references: Mol Cancer Ther. 2008 Sep;7(9):2725-35
references: 18790753
references: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5895-900
references: 17392427
references: Clin Toxicol. 1972;5(2):245-61
references: 5065665
references: Cancer Res. 2006 May 1;66(9):4627-35
references: 16651413
references: Oncogene. 2002 Nov 21;21(53):8196-205
references: 12444557
references: Science. 2007 Jul 20;317(5836):372-6
references: 17641202
references: Cancer Res. 2007 Mar 1;67(5):2187-96
references: 17332349
references: Mol Cancer. 2009;8:123
references: 20015350
references: Genes Dev. 2001 Dec 1;15(23):3059-87
references: 11731473
references: Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4254-9
references: 19246386
references: Nat Chem Biol. 2009 Mar;5(3):154-6
references: 19151731
references: Carcinogenesis. 2009 Jan;30(1):131-40
references: 19028702
references: Nature. 2003 Mar 20;422(6929):313-7
references: 12629553
references: EMBO Mol Med. 2012 Mar;4(3):218-33
references: 22294553
references: Mol Cancer Ther. 2012 Jan;11(1):57-65
references: 22084163
references: Annu Rev Cell Dev Biol. 2011;27:513-37
references: 21801010
references: Cancer Res. 2006 Jun 15;66(12):6063-71
references: 16778178
references: Int J Cancer. 2006 Jan 1;118(1):139-48
references: 16003737
references: Cancer Res. 2008 Apr 1;68(7):2241-9
references: 18381430
references: Curr Biol. 2007 Jan 23;17(2):165-72
references: 17196391
references: Stem Cells. 2007 Oct;25(10):2524-33
references: 17628016
references: N Engl J Med. 2009 Sep 17;361(12):1164-72
references: 19726763
references: Nature. 2009 Apr 9;458(7239):776-9
references: 19169242
references: Cancer Res. 2009 Aug 1;69(15):6007-10
references: 19638582
references: Oncogene. 2010 Dec 2;29(48):6314-22
references: 20802532
references: Cancer Res. 2011 Jun 1;71(11):4002-14
references: 21632555
references: Science. 2008 Sep 26;321(5897):1801-6
references: 18772397
references: Nature. 1999 Feb 18;397(6720):617-21
references: 10050855
references: Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4048-53
references: 17360475
references: EMBO Mol Med. 2009 Sep;1(6-7):338-51
references: 20049737
references: Int J Cancer. 2012 Jul 15;131(2):E33-44
references: 22072503
references: Mol Cancer. 2010;9:5
references: 20067614
references: Nat Med. 2001 Jun;7(6):706-11
references: 11385508
references: Sarcoma. 2012;2012:406239
references: 22619564
references: N Engl J Med. 2009 Sep 17;361(12):1173-8
references: 19726761
references: Cancer Res. 2005 Oct 1;65(19):8905-11
references: 16204062
references: Nat Genet. 1997 Mar;15(3):266-8
references: 9054938
references: Nature. 2000 Aug 31;406(6799):1005-9
references: 10984056
references: Science. 2009 Jun 12;324(5933):1457-61
references: 19460966
references: Cancer Res. 1989 Oct 1;49(19):5407-13
references: 2766305
references: Science. 2009 Oct 23;326(5952):572-4
references: 19726788
references: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4505-10
references: 16537363
references: Cancer Res. 2005 Jun 15;65(12):4975-8
references: 15958535
references: Carcinogenesis. 2005 Oct;26(10):1698-705
references: 15905200
references: Cancer Cell. 2008 Sep 9;14(3):238-49
references: 18772113
references: Biochem Pharmacol. 2014 Mar 1;88(1):1-11
references: 24231509
references: Science. 1987 Apr 3;236(4797):70-3
references: 3563490
references: Clin Cancer Res. 2008 Dec 1;14(23):7659-66
references: 19047091
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3196-201
references: 19218434
references: Proc Natl Acad Sci U S A. 2012 May 15;109(20):7859-64
references: 22550175
references: Nat Genet. 2013 Oct;45(10):1127-33
references: 24071851
references: Science. 2013 Mar 1;339(6123):1077-80
references: 23348505
references: Genes Cancer. 2010 Sep;1(9):941-51
references: 21779473
references: Clin Cancer Res. 2013 Jan 1;19(1):258-67
references: 23082002
references: Clin Cancer Res. 2010 Jul 1;16(13):3335-9
references: 20439455
references: Nature. 2012 Aug 23;488(7412):527-30
references: 22854777
references: Nat Rev Mol Cell Biol. 2013 Jul;14(7):416-29
references: 23719536
references: Cancer Res. 2004 Sep 1;64(17):6071-4
references: 15342389
references: Gut. 2006 Jul;55(7):991-9
references: 16299030
references: Cancer Lett. 2009 Oct 8;283(2):119-24
references: 19232458
references: Cancer Res. 2011 Jan 15;71(2):435-44
references: 21123452
references: Adv Cancer Res. 2011;110:1-17
references: 21704226
references: Mol Cancer Res. 2008 Dec;6(12):1928-36
references: 19074837